Spain, July 22 -- Spain based MERCK, S.L. has secured contract from Servicio Murciano de Salud - Junta de Compras for Antineoplastic and Immunomodulating Agents-Supply of exclusive medicines with active ingredients Avelumab, Cetumaximab, cladribin, interferon beta-1A and Tepotinib. The value of the contract is worth 92678400 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....